Список литературы

Поставить закладку

Practice Committee of American Society for Reproductive Medicine. Deﬁnitions of infertility and recurrent pregnancy loss: a committee opinion. Fertil Steril. 2013; 99(1):63.
Kolte A.M., Bernardi L.A., Christiansen O.B., Quenby S., Farquharson R.G., Goddijn M., et al. Terminology for pregnancy loss prior to viability: a consensus statement from the ESHRE early pregnancy special interest group. Hum Reprod. 2015; 30(3):495–8.
van den Boogaard E., Kaandorp S.P., Franssen M.T.M., Mol B.W.J., Leschot N.J., Wouters C.H., et al. Consecutive or non-consecutive recurrent miscarriage: is there any difference in carrier status? Hum Reprod. 2010; 25(6):1411–4.
Egerup P., Kolte A.M., Larsen E.C., Krog M., Nielsen H.S., Christiansen O.B. Recurrent pregnancy loss: what is the impact of consecutive versus non-consecutive losses? Hum Reprod. 2016; 31(11):2428–34.
Bashiri A., Ratzon R., Amar S., Serjienko R., Mazor M., Shoham-Vardi I. Two vs. three or more primary recurrent pregnancy losses--are there any differences in epidemiologic characteristics and index pregnancy outcome? J Perinat Med. 2012; 40(4):365–71.
Bhattacharya S., Townend J., Bhattacharya S. Recurrent miscarriage: Are three miscarriages one too many? Analysis of a Scottish population-based database of 151,021 pregnancies. Eur J Obstet Gynecol Reprod Biol. 2010; 150(1):24–7.
Lund M., Kamper-Jørgensen M., Nielsen H.S., Lidegaard Ø., Andersen A.-M.N., Christiansen O.B. Prognosis for live birth in women with recurrent miscarriage: what is the best measure of success? Obstet Gynecol. 2012; 119(1):37–43.
Christiansen O.B., Nybo Andersen A.-M., Bosch E., Daya S., Delves P.J., Hviid T. V, et al. Evidence-based investigations and treatments of recurrent pregnancy loss. Fertil Steril. 2005; 83(4):821–39.
Laurino M.Y., Bennett R.L., Saraiya D.S., Baumeister L., Doyle D.L., Leppig K., et al. Genetic Evaluation and Counseling of Couples with Recurrent Miscarriage: Recommendations of the National Society of Genetic Counselors. J Genet Couns. 2005; 14(3):165–81.
Robberecht C., Pexsters A., Deprest J., Fryns J.-P., D’Hooghe T., Vermeesch J.R. Cytogenetic and morphological analysis of early products of conception following hystero- embryoscopy from couples with recurrent pregnancy loss. Prenat Diagn. 2012; 32(10):933– 42.
Philipp T., Philipp K., Reiner A., Beer F., Kalousek D.K. Embryoscopic and cytogenetic analysis of 233 missed abortions: factors involved in the pathogenesis of developmental defects of early failed pregnancies. Hum Reprod. 2003; 18(8):1724–32.
Habbema J.D.F., Eijkemans M.J.C., Leridon H., te Velde E.R. Realizing a desired family size: when should couples start? Hum Reprod. 2015; 30(9):2215–21.
Fuchs F., Monet B., Ducruet T., Chaillet N., Audibert F. Effect of maternal age on the risk of preterm birth: A large cohort study. PLoS One. 2018; 13(1):e0191002.
Sharma R., Agarwal A., Rohra V.K., Assidi M., Abu-Elmagd M., Turki R.F. Effects of increased paternal age on sperm quality, reproductive outcome and associated epigenetic risks to offspring. Reprod Biol Endocrinol. 2015; 13:35.
Quenby S., Gallos I.D., Dhillon-Smith R.K., Podesek M., Stephenson M.D., Fisher J., et al. Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss. Lancet. 2021; 397(10285):1658–67.
Lo W., Rai R., Hameed A., Brailsford S.R., Al-Ghamdi A.A., Regan L. The effect of body mass index on the outcome of pregnancy in women with recurrent miscarriage. J Family Community Med. 2012; 19(3):167–71.
Boots C., Stephenson M.D. Does obesity increase the risk of miscarriage in spontaneous conception: a systematic review. Semin Reprod Med. 2011; 29(6):507–13.
Stefanidou E.M., Caramellino L., Patriarca A., Menato G. Maternal caffeine consumption and sine causa recurrent miscarriage. Eur J Obstet Gynecol Reprod Biol. 2011; 158(2):220–4.
Leung L.W.S., Davies G.A. Smoking Cessation Strategies in Pregnancy. J Obstet Gynaecol Can. 2015; 37(9):791–7.
Jensen T.K., Gottschau M., Madsen J.O.B., Andersson A.-M., Lassen T.H., Skakkebæk N.E., et al. Habitual alcohol consumption associated with reduced semen quality and changes in reproductive hormones; a cross-sectional study among 1221 young Danish men. BMJ Open. 2014; 4(9):e005462.
Saccone G., Perriera L., Berghella V. Prior uterine evacuation of pregnancy as independent risk factor for preterm birth: a systematic review and metaanalysis. Am J Obstet Gynecol. 2016; 214(5):572–91.
Nybo Andersen A.M., Wohlfahrt J., Christens P., Olsen J., Melbye M. Maternal age and fetal loss: population based register linkage study. BMJ. 2000; 320(7251):1708–12.
Goisis A., Remes H., Martikainen P., Klemetti R., Myrskylä M. Medically assisted reproduction and birth outcomes: a within-family analysis using Finnish population registers. Lancet (London, England). 2019; 393(10177):1225–32.
Савельева Г.М., Сухих Г.Т. С.В.Н. Акушерство. Национальное руководство. 2-е издание. 2018. 1735 p.
Carp H.J.A. Recurrent pregnancy loss Causes, Controversies and Treatment. 2015. 438 p.
Theoharides P.C., Christodoulou S., Athanasiou A. Spontaneous miscarriages in patients with bladder pain syndrome/interstitial cystitis - effect of stress on inﬂammation? J Biol Regul Homeost Agents. 35(1):5–10.
Cicinelli E., Matteo M., Tinelli R., Pinto V., Marinaccio M., Indraccolo U., et al. Chronic endometritis due to common bacteria is prevalent in women with recurrent miscarriage as conﬁrmed by improved pregnancy outcome after antibiotic treatment. Reprod Sci. 2014; 21(5):640–7.
McQueen D.B., Bernardi L.A., Stephenson M.D. Chronic endometritis in women with recurrent early pregnancy loss and/or fetal demise. Fertil Steril. 2014; 101(4):1026–30.
Koike T., Minakami H., Kosuge S., Usui R., Matsubara S., Izumi A., et al. Uterine leiomyoma in pregnancy: its inﬂuence on obstetric performance. J Obstet Gynaecol Res. 1999; 25(5):309–13.
Practice Committee of the American Society for Reproductive Medicine. Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril 1103–11. 2012; 98(5):1103–11.
Shapira E., Ratzon R., Shoham-Vardi I., Serjienko R., Mazor M., Bashiri A. Primary vs. secondary recurrent pregnancy loss--epidemiological characteristics, etiology, and next pregnancy outcome. J Perinat Med. 2012; 40(4):389–96.
American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Gynecology. ACOG Practice Bulletin No. 200: Early Pregnancy Loss. Obstet Gynecol. 2018; 132(5):e197–207.
Ectopic pregnancy ang miscarriage: diagnosis and initial management. NICE Guidel www.nice.org.uk/guidance/ng126. 2019; .
Queensland Clinical Guideline: Early Pregnancy Loss. 2017. 39p p.
van den Berg M.M.J., van Maarle M.C., van Wely M., Goddijn M. Genetics of early miscarriage. Biochim Biophys Acta. 2012; 1822(12):1951–9.
Franssen M.T.M., Korevaar J.C., Leschot N.J., Bossuyt P.M.M., Knegt A.C., Gerssen- Schoorl K.B.J., et al. Selective chromosome analysis in couples with two or more miscarriages: case-control study. BMJ. 2005; 331(7509):137–41.
Kolgeci S., Azemi M., Ahmeti H., Dervishi Z., Sopjani M., Kolgeci J. Recurrent abortions and down syndrome resulting from Robertsonian translocation 21q; 21q. Med Arch (Sarajevo, Bosnia Herzegovina). 2012; 66(5):350–2.
Robinson W.P., Bernasconi F., Basaran S., Yüksel-Apak M., Neri G., Serville F., et al. A somatic origin of homologous Robertsonian translocations and isochromosomes. Am J Hum Genet. 1994; 54(2):290–302.
Козлова С.И., Демикова Н.С под ред.академика РАМН проф. Е.К.Г. Наследственные синдромы и медико-генетическое консультирование. 2007. 361 p.
Sahoo T., Dzidic N., Strecker M.N., Commander S., Travis M.K., Doherty C., et al. Comprehensive genetic analysis of pregnancy loss by chromosomal microarrays: outcomes, beneﬁts, and challenges. Genet Med. 2017; 19(1):83–9.
Coomarasamy A., Dhillon-Smith R.K., Papadopoulou A., Al-Memar M., Brewin J., Abrahams V.M., et al. Recurrent miscarriage: evidence to accelerate action. Lancet. 2021; 397(10285):1675–82.
Miyakis S., Lockshin M.D., Atsumi T., Branch D.W., Brey R.L., Cervera R., et al. International consensus statement on an update of the classiﬁcation criteria for deﬁnite antiphospholipid syndrome (APS). J Thromb Haemost. 2006; 4(2):295–306.
Thangaratinam S., Tan A., Knox E., Kilby M.D., Franklyn J., Coomarasamy A. Association between thyroid autoantibodies and miscarriage and preterm birth: meta- analysis of evidence. BMJ. 2011; 342:d2616.
Ticconi C., Giuliani E., Veglia M., Pietropolli A., Piccione E., Di Simone N. Thyroid autoimmunity and recurrent miscarriage. Am J Reprod Immunol. 2011; 66(6):452–9.
Vissenberg R., Manders V.D., Mastenbroek S., Fliers E., Aﬁnk G.B., Ris-Stalpers C., et al. Pathophysiological aspects of thyroid hormone disorders/thyroid peroxidase autoantibodies and reproduction. Hum Reprod Update. 21(3):378–87.
Anselmo J., Cao D., Karrison T., Weiss R.E., Refetoff S. Fetal loss associated with excess thyroid hormone exposure. JAMA. 2004; 292(6):691–5.
van den Boogaard E., Vissenberg R., Land J.A., van Wely M., van der Post J.A.M., Goddijn M., et al. Signiﬁcance of (sub)clinical thyroid dysfunction and thyroid autoimmunity before conception and in early pregnancy: a systematic review. Hum Reprod Update. 17(5):605–19.
Practice Committee of the American Society for Reproductive Medicine. Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril. 2012; 98(5):1103–11.
Ke R.W. Endocrine basis for recurrent pregnancy loss. Obstet Gynecol Clin North Am. 2014; 41(1):103–12.
Holmes V.A., Hamill L.L., Alderdice F.A., Spence M., Harper R., Patterson C.C., et al. Effect of implementation of a preconception counselling resource for women with diabetes: A population based study. Prim Care Diabetes. 2017; 11(1):37–45.
Edugbe A.E., James B., Akunaeziri U.A., Egbodo C.O., Imoh C.L., Ajen A.S., et al. Beta-cell dysfunction and abnormal glucose metabolism among non-diabetic women with recurrent miscarriages. Arch Gynecol Obstet. 2020; 301(2):559–64.
Gutaj P., Zawiejska A., Wender-Ożegowska E., Brązert J. Maternal factors predictive of ﬁrst‑trimester pregnancy loss in women with pregestational diabetes. Pol Arch Med Wewn. 2013; 123(1–2):21–8.
Nardo L.G., Rai R., Backos M., El-Gaddal S., Regan L. High serum luteinizing hormone and testosterone concentrations do not predict pregnancy outcome in women with recurrent miscarriage. Fertil Steril. 2002; 77(2):348–52.
Rai R., Backos M., Rushworth F., Regan L. Polycystic ovaries and recurrent miscarriage--a reappraisal. Hum Reprod. 2000; 15(3):612–5.
Shah D., Nagarajan N. Luteal insufﬁciency in ﬁrst trimester. Indian J Endocrinol Metab. 2013; 17(1):44–9.
Recurrent pregnancy loss. Guideline of the European Society of Human Reproduction and Embryology (ESHRE). 154p. https://www.eshre.eu/Guidelines-and-Legal/Guidelines/Recurrent-pregnancy-loss.aspx.
Wathen N.C., Perry L., Lilford R.J., Chard T. Interpretation of single progesterone measurement in diagnosis of anovulation and defective luteal phase: observations on analysis of the normal range. Br Med J (Clin Res Ed). 1984; 288(6410):7–9.
Steer P., Alam M.A., Wadsworth J., Welch A. Relation between maternal haemoglobin concentration and birth weight in different ethnic groups. BMJ. 1995; 310(6978):489–91.
Zhou L.M., Yang W.W., Hua J.Z., Deng C.Q., Tao X., Stoltzfus R.J. Relation of hemoglobin measured at different times in pregnancy to preterm birth and low birth weight in Shanghai, China. Am J Epidemiol. 1998; 148(10):998–1006.
Nair M., Churchill D., Robinson S., Nelson-Piercy C., Stanworth S.J., Knight M. Association between maternal haemoglobin and stillbirth: a cohort study among a multi- ethnic population in England. Br J Haematol. 2017; 179(5):829–37.
Young M.F., Oaks B.M., Tandon S., Martorell R., Dewey K.G., Wendt A.S. Maternal hemoglobin concentrations across pregnancy and maternal and child health: a systematic review and meta-analysis. Ann N Y Acad Sci. 2019; 1450(1):47–68.
Breymann C. Iron supplementation during pregnancy. Fetal Matern Med Rev. 2002; 13(1):1–29.
Georgsen M., Krog M.C., Korsholm A.-S., Hvidman H.W., Kolte A.M., Rigas A.S., et al. Serum ferritin level is inversely related to number of previous pregnancy losses in women with recurrent pregnancy loss. Fertil Steril. 2021; 115(2):389–96.
Haahr T., Zacho J., Bräuner M., Shathmigha K., Skov Jensen J., Humaidan P. Reproductive outcome of patients undergoing in vitro fertilisation treatment and diagnosed with bacterial vaginosis or abnormal vaginal microbiota: a systematic PRISMA review and meta-analysis. BJOG. 2019; 126(2):200–7.
Косметологов Р. общество дерматовенерологов и. Клинические рекомендации: Бактериальный вагиноз. 2020; .
РОАГ. Клинические рекомендации по диагностике и лечению заболеваний, сопровождающихся патологическими выделениями из половых путей женщин. 2019; .
Nigro G., Mazzocco M., Mattia E., Di Renzo G.C., Carta G., Anceschi M.M. Role of the infections in recurrent spontaneous abortion. J Matern Neonatal Med. 2011; 24(8):983–9.
Lashley E.E.L.O., Meuleman T., Claas F.H.J. Beneﬁcial or harmful effect of antipaternal human leukocyte antibodies on pregnancy outcome? A systematic review and meta-analysis. Am J Reprod Immunol. 2013; 70(2):87–103.
Bartel G., Walch K., Wahrmann M., Pils S., Küssel L., Polterauer S., et al. Prevalence and qualitative properties of circulating anti-human leukocyte antigen alloantibodies after pregnancy: no association with unexplained recurrent miscarriage. Hum Immunol. 2011; 72(2):187–92.
Sklyarova V., Kyshakevych I., Volosovsky P., Sklyarov P., Kupchak I. ; EPIDEMIOLOGICAL FEATURES OF CHRONIC ENDOMETRITIS IN REPRODUCTIVE AGE WOMEN WITH DISORDERS OF REPRODUCTIVE HEALTH. Georgian Med News. (304– 305):27–32.
World Health Organization. WHO laboratory manual for the examination and processing of human semen - 5th ed. 2010. 287 p.
Долгушина Н.В., Ратушняк С.С., Сокур С.А., Глинкина Ж.И., Калинина Е.А. Риск анеуплоидии эмбрионов в программах вспомогательных репродуктивных технологий у мужчин с патозооспермией (мета-анализ). Акушерство и гинекология. 2012; 7:4–13.
Zhang L., Wang L., Zhang X., Xu G., Zhang W., Wang K., et al. Sperm chromatin integrity may predict future fertility for unexplained recurrent spontaneous abortion patients. Int J Androl. 2012; 35(5):752–7.
Jungwirth A., Diemer T., Kopa Z. Male Infertility. EAU guidelines. 2016.
Чалый М.Е., Ахвледиани Н.Д., Харчилава Р.Р. Мужское бесплодие. Российские клинические рекомендации. Урология. 2016; (1):2–16.
Rowe P.J., Comhaire F.H., Hargreave T.B., Mellows H.J. WHO Manual for the Standardized Investigation, Diagnosis and Management of the Infertile Male. 2000. 102 p.
Корнеев И.А., Зассеев Р.Д., Исакова Э.В., Кинунен А.А., Бичевая Н.К. Оказание медицинской помощи с применением вспомогательных репродуктивных технологий у мужчин: обзор клинических рекомендаций и алгоритм маршрутизации пациентов. Проблемы репродукции. 2018; 24(4):59–65.
Bradley L.A., Palomaki G.E., Bienstock J., Varga E., Scott J.A. Can Factor V Leiden and prothrombin G20210A testing in women with recurrent pregnancy loss result in improved pregnancy outcomes?: Results from a targeted evidence-based review. Genet Med. 2012; 14(1):39–50.
Liu X., Chen Y., Ye C., Xing D., Wu R., Li F., et al. Hereditary thrombophilia and recurrent pregnancy loss: a systematic review and meta-analysis. Hum Reprod. 2021; 36(5):1213–29.
Hamedi B., Feulefack J., Khan A., Sergi C. Association between factor V Leiden mutation and recurrent pregnancy loss in the middle east countries: a Newcastle–Ottawa meta-analysis. Arch Gynecol Obstet. 2020; 302(2):345–54.
Gao H., Tao F. Prothrombin G20210A mutation is associated with recurrent pregnancy loss: A systematic review and meta-analysis update. Thromb Res. 2015; 135(2):339–46.
Sergi C., Al Jishi T., Walker M. Factor V Leiden mutation in women with early recurrent pregnancy loss: a meta-analysis and systematic review of the causal association. Arch Gynecol Obstet. 2015; 291(3):671–9.
Kovalevsky G., Gracia C.R., Berlin J.A., Sammel M.D., Barnhart K.T. Evaluation of the Association Between Hereditary Thrombophilias and Recurrent Pregnancy Loss. Arch Intern Med. 2004; 164(5):558.
Rey E., Kahn S.R., David M., Shrier I. Thrombophilic disorders and fetal loss: a meta- analysis. Lancet. 2003; 361(9361):901–8.
The Investigation and Treatment of Couples with Recurrent First-trimester and Second-trimester Miscarriage. RCOG Green-top Guidel No 17. 2011; .
Toth B., Würfel W., Bohlmann M., Zschocke J., Rudnik-Schöneborn S., Nawroth F., et al. Recurrent Miscarriage: Diagnostic and Therapeutic Procedures. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry Number 015/050). Geburtshilfe Frauenheilkd. 2018; 78(4):364–81.
Bender Atik R., Christiansen O.B., Elson J., Kolte A.M., Lewis S., Middeldorp S., et al. ESHRE guideline: recurrent pregnancy loss. Hum Reprod Open. 2018; 2018(2).
Berghella V., Palacio M., Ness A., Alﬁrevic Z., Nicolaides K.H., Saccone G. Cervical length screening for prevention of preterm birth in singleton pregnancy with threatened preterm labor: systematic review and meta-analysis of randomized controlled trials using individual patient-level data. Ultrasound Obstet Gynecol. 2017; 49(3):322–9.
Newman R.B., Goldenberg R.L., Iams J.D., Meis P.J., Mercer B.M., Moawad A.H., et al. Preterm prediction study: comparison of the cervical score and Bishop score for prediction of spontaneous preterm delivery. Obstet Gynecol. 2008; 112(3):508–15.
Norman J.E., Marlow N., Messow C.-M., Shennan A., Bennett P.R., Thornton S., et al. Does progesterone prophylaxis to prevent preterm labour improve outcome? A randomised double-blind placebo-controlled trial (OPPTIMUM). Health Technol Assess. 2018; 22(35):1– 304.
Medley N., Poljak B., Mammarella S., Alﬁrevic Z. Clinical guidelines for prevention and management of preterm birth: a systematic review. BJOG. 2018; 125(11):1361–9.
Alﬁrevic Z., Navaratnam K., Mujezinovic F. Amniocentesis and chorionic villus sampling for prenatal diagnosis. Cochrane database Syst Rev. 2017; 9:CD003252.
Beta J., Lesmes-Heredia C., Bedetti C., Akolekar R. Risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review of the literature. Minerva Ginecol. 2018; 70(2):215–9.
Akolekar R., Beta J., Picciarelli G., Ogilvie C., D’Antonio F. Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2015; 45(1):16–26.
Сухих Г.Т., Трофимов Д.Ю., Барков И.Ю., Донников А.Е. Ш.Е.С., Коростин Д.О., Екимов А.Н., Гольцов А.Ю., Бахарев В.А. К., Н.А., Боровиков П.И., Тетруашвили Н.К., Ким Л.В., Павлович С.В. С., К.Г., Прохорчук Е.Б., Мазур А.М. П.К.С. Неинвазивный пренатальный ДНК-скрининг анеуплодий плода по крови матери методом высокопроизводительного секвенирования. Акушерство и гинекология. 2016; (6):3–22.
Cavalcante M.B., Sarno M., Peixoto A.B., Araujo Júnior E., Barini R. Obesity and recurrent miscarriage: A systematic review and meta-analysis. J Obstet Gynaecol Res. 2019; 45(1):30–8.
Ng K.Y.B., Cherian G., Kermack A.J., Bailey S., Macklon N., Sunkara S.K., et al. Systematic review and meta-analysis of female lifestyle factors and risk of recurrent pregnancy loss. Sci Rep. 2021; 11(1):7081.
Ofﬁce of the Surgeon General (US), Ofﬁce on Smoking and Health (US). The health consequences of smoking: a report of the Surgeon General. Atlanta (GA): Centers for Disease Control and Prevention (US); 2004. 2004; .
Salmasi G., Grady R., Jones J., McDonald S.D., Knowledge Synthesis Group. Environmental tobacco smoke exposure and perinatal outcomes: a systematic review and meta-analyses. Acta Obstet Gynecol Scand. 2010; 89(4):423–41.
Castles A., Adams E.K., Melvin C.L., Kelsch C., Boulton M.L. Effects of smoking during pregnancy. Five meta-analyses. Am J Prev Med. 1999; 16(3):208–15.
Dietz P.M., England L.J., Shapiro-Mendoza C.K., Tong V.T., Farr S.L., Callaghan W.M. Infant morbidity and mortality attributable to prenatal smoking in the U.S. Am J Prev Med. 2010; 39(1):45–52.
American College of Obstetricians and Gynecologists. Committee on Health Care for Underserved Women. Committee opinion no. 496: At-risk drinking and alcohol dependence: obstetric and gynecologic implications. Obstet Gynecol. 2011; 118(2 Pt 1):383–8.
Williams J.F., Smith V.C., Committee on substance abuse. Fetal Alcohol Spectrum Disorders. Pediatrics. 2015; 136(5):e1395-406.
Tobiasz AM, Duncan JR, Bursac Z et al. The Effect of Prenatal Alcohol Exposure on Fetal Growth and Cardiovascular Parameters in a Baboon Model of Pregnancy. Reprod Sci. 2018; 25(7):1116–23.
Seleverstov O, Tobiasz A, Jackson JS et al. Maternal alcohol exposure during mid- pregnancy dilates fetal cerebral arteries via endocannabinoid receptors. Alcohol. 2017; (61):51–61.
Lo JO, Schabel MC, Roberts VH et al. First trimester alcohol exposure alters placental perfusion and fetal oxygen availability affecting fetal growth and development in a non- human primate model. Am J Obs Gynecol. 2017; 216(3):302.e1-302.e8.
Chen L.-W., Wu Y., Neelakantan N., Chong M.F.-F., Pan A., van Dam R.M. Maternal caffeine intake during pregnancy is associated with risk of low birth weight: a systematic review and dose-response meta-analysis. BMC Med. 2014; 12(1):174.
Rhee J., Kim R., Kim Y., Tam M., Lai Y., Keum N., et al. Maternal Caffeine Consumption during Pregnancy and Risk of Low Birth Weight: A Dose-Response Meta- Analysis of Observational Studies. Zhang B, editor. PLoS One. 2015; 10(7):e0132334.
Chen L.-W., Wu Y., Neelakantan N., Chong M.F.-F., Pan A., van Dam R.M. Maternal caffeine intake during pregnancy and risk of pregnancy loss: a categorical and dose– response meta-analysis of prospective studies. Public Health Nutr. 2016; 19(07):1233–44.
Li J., Zhao H., Song J.-M., Zhang J., Tang Y.-L., Xin C.-M. A meta-analysis of risk of pregnancy loss and caffeine and coffee consumption during pregnancy. Int J Gynecol Obstet. 2015; 130(2):116–22.
Tan C., Zhao Y., Wang S. Is a vegetarian diet safe to follow during pregnancy? A systematic review and meta-analysis of observational studies. Crit Rev Food Sci Nutr. 2018; :1–40.
Здоровое питание. Информационный бюллетень. Женева: Всемирная организация здравоохранения. 31 августа 2018 г. [https://www.who.int/ru/news- room/fact-sheets/detail/healthy-diet].
Coomarasamy A., Devall A.J., Brosens J.J., Quenby S., Stephenson M.D., Sierra S., et al. Micronized vaginal progesterone to prevent miscarriage: a critical evaluation of randomized evidence. Am J Obstet Gynecol. 2020; 223(2):167–76.
Wahabi H.A., Fayed A.A., Esmaeil S.A., Bahkali K.H. Progestogen for treating threatened miscarriage. Cochrane database Syst Rev. 2018; 8:CD005943.
Pandian R.U. Dydrogesterone in threatened miscarriage: a Malaysian experience. Maturitas. 2009; 65 Suppl 1:S47-50.
Coomarasamy A., Williams H., Truchanowicz E., Seed P.T., Small R., Quenby S., et al. A Randomized Trial of Progesterone in Women with Recurrent Miscarriages. N Engl J Med. 2015; 373(22):2141–8.
Saccone G., Schoen C., Franasiak J.M., Scott R.T., Berghella V. Supplementation with progestogens in the ﬁrst trimester of pregnancy to prevent miscarriage in women with unexplained recurrent miscarriage: a systematic review and meta-analysis of randomized, controlled trials. Fertil Steril. 2017; 107(2):430-438.e3.
Lee H.J., Park T.C., Kim J.H., Norwitz E., Lee B. The Inﬂuence of Oral Dydrogesterone and Vaginal Progesterone on Threatened Abortion: A Systematic Review and Meta-Analysis. Biomed Res Int. 2017; 2017:3616875.
Wang X.-X., Luo Q., Bai W.-P. Efﬁcacy of progesterone on threatened miscarriage: Difference in drug types. J Obstet Gynaecol Res. 2019; 45(4):794–802.
Haas D.M., Hathaway T.J., Ramsey P.S. Progestogen for preventing miscarriage in women with recurrent miscarriage of unclear etiology. Cochrane database Syst Rev. 2019; 2019(11).
Савельева Г.М., Аксененко В.А., Андреева М.Д., Базина М.И., Башмакова Н.В., Боровкова Л.В., Брюхина Е.В., Буштырева И.О., Волков В.Г., Гурьев Д.Л., Данькова И.В., Доброхотова Ю.Э., Егорова А.Т., Иванова Т.В., Константинова О.Д., Коротких И.Н., Кравченко Е Я.М.И. No Title. Акушерство и гинекология. 2017; (11):26–37.
Kumar A., Begum N., Prasad S., Aggarwal S., Sharma S. Oral dydrogesterone treatment during early pregnancy to prevent recurrent pregnancy loss and its role in modulation of cytokine production: a double-blind, randomized, parallel, placebo-controlled trial. Fertil Steril. 2014; 102(5):1357-1363.e3.
Coomarasamy A., Devall A.J., Cheed V., Harb H., Middleton L.J., Gallos I.D., et al. A Randomized Trial of Progesterone in Women with Bleeding in Early Pregnancy. N Engl J Med. 2019; 380(19):1815–24.
Г.Т. С. The conclusion of the Expert Council on the results of the 2nd World Congress of Medicine of the Mother, Fetus and Newborn “Micronized progesterone in the treatment of miscarriage.” Probl reproduktsii. 2019; 25(2):46.
Сухих. Resolution of the Advisory Board on the subject: Multicenter Open-Label Observational Program to Research on Predictors of Pregnancy Rate in Assisted Reproductive Technology in the Russian Population According to Actual International and National Guidelin. Akush Ginekol (Soﬁia). 2019; 12_2019(12):218–24.
Carp H.J.A. Progestogens and pregnancy loss. Climacteric. 2018; 21(4):380–4.
Tetruashvili N.K., Agadzhanova A.A. Dydrogesterone in the treatment of the threatened and habitual miscarriage. Med Counc. 2018; (13):68–72.
Chan D.M.K., Cheung K.W., Ko J.K.Y., Yung S.S.F., Lai S.F., Lam M.T., et al. Use of oral progestogen in women with threatened miscarriage in the ﬁrst trimester: a randomized double-blind controlled trial. Hum Reprod. 2021; 36(3):587–95.
Devall A.J., Papadopoulou A., Podesek M., Haas D.M., Price M.J., Coomarasamy A., et al. Progestogens for preventing miscarriage: a network meta-analysis. Cochrane database Syst Rev. 2021; 4:CD013792.
В.Н. С. Комментарий к статье: “Применение перорального гестагена у женщин с угрожающим выкидышем в первом триместре: рандомизированное двойное слепое плацебо-контролируемое исследование”. Акушерство и гинекология. 2020; .
Arab H., Alharbi A. jaber, Oraif A., Sagr E., Al Madani H., Abduljabbar H., et al. The Role Of Progestogens In Threatened And Idiopathic Recurrent Miscarriage. Int J Womens Health. 2019; Volume 11:589–96.
Griesinger G., Blockeel C., Kahler E., Pexman-Fieth C., Olofsson J.I., Driessen S., et al. Dydrogesterone as an oral alternative to vaginal progesterone for IVF luteal phase support: A systematic review and individual participant data meta-analysis. PLoS One. 2020; 15(11):e0241044.
Broekmans F., Humaidan P., Lainas G., Töyli M., Le Clef N., Vermeulen N. Reply: Questionable recommendation for LPS for IVF/ICSI in ESHRE guideline 2019: ovarian stimulation for IVF/ICSI. Hum Reprod open. 2021; 2021(1):hoab006.
Hamulyák E.N., Scheres L.J., Marijnen M.C., Goddijn M., Middeldorp S. Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss. Cochrane database Syst Rev. 2020; 5:CD012852.
Clark P., Walker I.D., Langhorne P., Crichton L., Thomson A., Greaves M., et al. SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low- molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage. Blood. 2010; 115(21):4162–7.
Areia A.L., Fonseca E., Areia M., Moura P. Low-molecular-weight heparin plus aspirin versus aspirin alone in pregnant women with hereditary thrombophilia to improve live birth rate: meta-analysis of randomized controlled trials. Arch Gynecol Obstet. 2016; 293(1):81–6.
WHO Recommendations on Antenatal Care for a Positive Pregnancy ExperienceNo Title.
Johnston-MacAnanny E.B., Hartnett J., Engmann L.L., Nulsen J.C., Sanders M.M., Benadiva C.A. Chronic endometritis is a frequent ﬁnding in women with recurrent implantation failure after in vitro fertilization. Fertil Steril. 2010; 93(2):437–41.
Toth B., Würfel W., Bohlmann M., Zschocke J., Rudnik-Schöneborn S., Nawroth F., et al. Recurrent Miscarriage: Diagnostic and Therapeutic Procedures. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry Number 015/050). Geburtshilfe Frauenheilkd. 2018; 78(04):364–81.
Pabuccu R., Onalan G., Kaya C., Selam B., Ceyhan T., Ornek T., et al. Efﬁciency and pregnancy outcome of serial intrauterine device-guided hysteroscopic adhesiolysis of intrauterine synechiae. Fertil Steril. 2008; 90(5):1973–7.
Soares S.R., Barbosa dos Reis M.M., Camargos A.F. Diagnostic accuracy of sonohysterography, transvaginal sonography, and hysterosalpingography in patients with uterine cavity diseases. Fertil Steril. 2000; 73(2):406–11.
Practice Committee of the American Society for Reproductive Medicine. Committee opinion: role of tubal surgery in the era of assisted reproductive technology. Fertil Steril. 2012; 97(3):539–45.
Smith S., Pfeifer S.M., Collins J.A. Diagnosis and management of female infertility. JAMA. 2003; 290(13):1767–70.
Balasch J. Investigation of the infertile couple: investigation of the infertile couple in the era of assisted reproductive technology: a time for reappraisal. Hum Reprod. 2000; 15(11):2251–7.
Luttjeboer F.Y., Verhoeve H.R., van Dessel H.J., van der Veen F., Mol B.W.J., Coppus S.F.P.J. The value of medical history taking as risk indicator for tuboperitoneal pathology: a systematic review. BJOG. 2009; 116(5):612–25.
Perquin D.A.M., Dörr P.J., de Craen A.J.M., Helmerhorst F.M. Routine use of hysterosalpingography prior to laparoscopy in the fertility workup: a multicentre randomized controlled trial. Hum Reprod. 2006; 21(5):1227–31.
Shennan A., Chandiramani M., Bennett P., David A.L., Girling J., Ridout A., et al. MAVRIC: a multicenter randomized controlled trial of transabdominal vs transvaginal cervical cerclage. Am J Obstet Gynecol. 2020; 222(3):261.e1-261.e9.

Для продолжения работы требуется Регистрация

Предыдущая страница

Следующая страница

Приложение А3. Справочные материалы, включая соответствие показаний к применению и противопоказаний, способов применения и доз лекарственных препаратов, инструкции по применению лекарственного препарата

Приложение Б. Алгоритмы действий врача

Приложение В. Информация для пациента

Данный блок поддерживает скрол*